Glaucoma Treatments in 2021: Personalizing Patient Needs

Glaucoma Treatments in 2021: Personalizing Patient Needs is organized by Evolve Medical Education (EME) LLC

Release Date: Nov 29, 2021
Expiry Date: Oct 31, 2024

Learning Objectives:
Upon completion of this activity, the participant should be able to:
• Describe the mechanisms of action of novel therapeutics and classes of drugs for ocular hypertension (OHT) and primary open angle glaucoma (POAG)
• Interpret the challenges and limitations associated with currently available pharmacologic treatment options for OHT and POAG
• Evaluate monotherapy and combination regimens and compare which option is most likely to achieve each individual patient’s goal IOP
• Compare and assess the efficacy of novel therapeutics with traditional prostaglandins

Additional details will be posted as soon as information is available.